logo
Select company
Select metric
Ticker Information

Ticker

RVPH

Company Name

REVIVA PHARMACEUTICALS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REVIVA PHARMACEUTICALS HOLDINGS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RVPH - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -459.15K$ -27.11M0%
3/31/2025$ -4.46M$ -28.92M0%
12/31/2024$ 812.57K$ -29.92M-3681.99%
9/30/2024$ -9.98M$ -33.38M0%
6/30/2024$ -6.04M$ -35.51M0%
3/31/2024$ -1.35M$ -40.09M0%
12/31/2023$ 5.72M$ -39.26M-686.53%
9/30/2023$ -8.52M$ -37.65M0%
6/30/2023$ 1.62M$ -30.68M-1892.38%
3/31/2023$ 5.78M$ -23.58M-407.55%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REVIVA PHARMACEUTICALS HOLDINGS INC's latest trailing twelve months (TTM) ROE stands at -23.03%.
  • Over the past 5 years, REVIVA PHARMACEUTICALS HOLDINGS INC's average ROE has been -720.28%.
  • The median ROE for REVIVA PHARMACEUTICALS HOLDINGS INC during this period was -156.93%
  • REVIVA PHARMACEUTICALS HOLDINGS INC reached its highest ROE over the past 5 years at -23.03%.
  • The lowest ROE recorded by REVIVA PHARMACEUTICALS HOLDINGS INC in the same timeframe -3681.99%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for REVIVA PHARMACEUTICALS HOLDINGS INC is calculated as follows: Net Inc. Cmn. [ $ -1.15M ] / Equity [ $ 5M ]
(=) ROE [ -23.03% ]

RVPH - Return on Equity, Last 5 years

-3681.99%

Minimum

Dec 31, 2024

-23.03%

Maximum

Dec 31, 2020

-720.28%

Average

-156.93%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.56% with a standard deviation of 22.62%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.66%
max73.25%
average1.56%
median6.45%
std22.62%